Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-19-009889
Filing Date
2019-04-03
Accepted
2019-04-03 20:17:13
Documents
2
Period of Report
2019-04-02

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 5364
2 EX-24 DOCUMENT attachment1.htm EX-24 3969
  Complete submission text file 0000899243-19-009889.txt   10696
Mailing Address C/O SATTER INVESTMENT MANAGEMENT, LLC 676 NORTH MICHIGAN AVENUE, SUITE 4000 CHICAGO IL 60611
Business Address
Satter Muneer A (Reporting) CIK: 0001315797 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38130 | Film No.: 19730895

Mailing Address 490 ARSENAL WAY WATERTOWN MA 02472
Business Address 490 ARSENAL WAY WATERTOWN MA 02472 617-995-0900
AILERON THERAPEUTICS INC (Issuer) CIK: 0001420565 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations